Erbevio3apc3
Payments companies reported to CMS as associated with Erbevio3apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbevio3apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbevio3apc3
These are the largest totals companies reported as associated with Erbevio3apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ryan Burden | Jefferson, LA | Hospitalist | $150.00 |
| Mohammad Sultan | New Orleans, LA | Internal Medicine | $150.00 |
| Paula Cacioppo | Jefferson, LA | Internal Medicine | $150.00 |
| Adil Memon | Jefferson, LA | Internal Medicine | $150.00 |
| Paul Gomez | Jefferson, LA | Gastroenterology (Internal Medicine) | $150.00 |
Prescribed Erbevio3apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.